SCHEMBL3417161

SCHEMBL3417161

O=CC(Br)c1cc2cc(Cl)ccc2o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.50
ALOX5 P09917 1/20 0.48
KDM4E B2RXH2 5/20 0.44
GPR35 Q9HC97 2/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
KMT2A Q03164 2/20 0.43
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
HSD17B10 Q99714 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP19A1 P11511 1/20 0.39
APP P05067 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3721824 0.83 CYP2A6 (0.57) GPR35ALDH1A1CA1CA2KMT2A
SCHEMBL2043200 0.79 CYP2A6 (0.52) MAOBKDM4EGPR35ALDH1A1CA1
SCHEMBL11190837 0.79 ALOX5 (0.54) MAOBALOX5KDM4EGPR35ALDH1A1
SCHEMBL17541032 0.78 CYP2A6 (0.50) MAOBKDM4EALDH1A1CA1CA2
SCHEMBL12248487 0.74 ALOX5 (0.56) MAOBALOX5KDM4EGPR35ALDH1A1
SCHEMBL120463 0.73 CYP2A6 (0.62) MAOBALOX5KDM4EGPR35ALDH1A1
SCHEMBL28518711 0.72 GPR35 (0.51) MAOBALOX5KDM4EGPR35ALDH1A1
SCHEMBL20559684 0.71 ALOX5 (0.57) MAOBALOX5KDM4EGPR35ALDH1A1
SCHEMBL10459871 0.71 ALOX5 (0.57) MAOBALOX5KDM4EGPR35ALDH1A1
SCHEMBL11346189 0.71 ALOX5 (0.57) MAOBALOX5KDM4EGPR35ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265606-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2010-12-29 EP disclosed
WO-2009129109-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-22 WO disclosed